Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Common Equity: 2009-2024

Historic Common Equity for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to $764.9 million.

  • Pediatrix Medical's Common Equity rose 2159.4% to $890.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $890.7 million, marking a year-over-year increase of 2159.4%. This contributed to the annual value of $764.9 million for FY2024, which is 990.78% down from last year.
  • As of FY2024, Pediatrix Medical's Common Equity stood at $764.9 million, which was down 990.78% from $849.1 million recorded in FY2023.
  • In the past 5 years, Pediatrix Medical's Common Equity registered a high of $896.7 million during FY2021, and its lowest value of $747.7 million during FY2020.
  • Over the past 5 years, Pediatrix Medical's median Common Equity value was $849.1 million (recorded in 2023), while the average stood at $830.0 million.
  • Its Common Equity has fluctuated over the past 5 years, first plummeted by 5011.88% in 2020, then surged by 1992.4% in 2021.
  • Pediatrix Medical's Common Equity (Annual) stood at $747.7 million in 2020, then grew by 19.92% to $896.7 million in 2021, then fell by 0.56% to $891.6 million in 2022, then decreased by 4.77% to $849.1 million in 2023, then decreased by 9.91% to $764.9 million in 2024.
  • Its Common Equity was $764.9 million in FY2024, compared to $849.1 million in FY2023 and $891.6 million in FY2022.